Skip to main content
SpringerLink
Log in

Morbidity and mortality of hospitalized patients with diffuse idiopathic skeletal hyperostosis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Diffuse idiopathic skeletal hyperostosis (DISH) has been associated with various metabolic disorders considered to be cardiovascular risk factors such as obesity, diabetes mellitus, hyperinsulinemia, and hyperlipidemia. To evaluate morbidity and mortality of hospitalized patients with DISH admitted to the department of medicine. One hundred patients from a cohort of 1020 consecutive patients, aged 45 years and more, admitted to the department of medicine were diagnosed as suffering from DISH. Another group of 100 patients, age- and gender matched, admitted without DISH, served as controls. Clinical and demographic characteristics, diagnoses on admission, previous chronic diseases, chronic medical therapy, laboratory tests, and the rates of in-hospital mortality and readmissions within 1 month of discharge were collected from the hospital database, for the two groups. Uncompensated or paroxysmal atrial fibrillation was more often encountered on admission in patients with DISH (p=0.038). Patients with DISH were more likely to suffer from elevated body mass index, arterial hypertension, diabetes mellitus, and previous cerebral vascular accidents, although the differences did not reach statistical significance. However, significantly more patients had an electrocardiographic evidence of left ventricular hypertrophy (p=0.03). The mortality rate was similar between the two groups. The lack of significant associations for cardiovascular risk factors such as diabetes mellitus, hypertension, and high BMI should be interpreted cautiously considering the characteristics of the control group. Identification of comorbid conditions and proper therapeutic interventions may prove useful in reducing the morbidity and mortality associated with this disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Forestier J, Rotes-Querol J (1950) Senile ankylosing hyperostosis of the spine. Ann Rheum Dis 9:321–330

    CAS  PubMed  Google Scholar 

  2. Resnick D, Niwayama G (1976) Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology 119:559–568

    CAS  PubMed  Google Scholar 

  3. Resnick D, Niwayama G (1988) Diagnosis of bone and joint disorders, 2nd edn. Saunders, Philadelphia, pp 1563–1615

  4. Littlejohn GO, Smythe HA (1981) Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J Rheumatol 8:965–968

    CAS  PubMed  Google Scholar 

  5. Littlejohn GO, Hall S (1982) Diffuse idiopathic skeletal hyperostosis and new bone formation in male gouty subjects. A radiologic study. Rheumatol Int 2:83–86

    CAS  PubMed  Google Scholar 

  6. Vezyroglu G, Mitropoulos A, Kyriazis N, Antoniadis C (1996) A metabolic syndrome in diffuse idiopathic skeletal hyperostos: a controlled study. J Rheumatol 23:672–676

    CAS  PubMed  Google Scholar 

  7. Dougados M, Leporho MA, Esmilaire L et al. (1988) Taux plasmatiques des vitamines A et E au cours de la maladie hyperostosique, la spondyloarthrite ankylosante, et la polyarthrite rheumatoide. Rev Rhum Mal Osteoartic 55:251–254

    CAS  PubMed  Google Scholar 

  8. Mata S, Hill RO, Joseph L, Kaplan P et al. (1993) Chest radiographs as a screening tool for diffuse idiopathic skeletal hyperostosis. J Rheumatol 20:1905–1910

    CAS  PubMed  Google Scholar 

  9. Mader R Diffuse idiopathic skeletal hyperostosis (DISH): a distinct clinical entity. IMAJ

  10. Julkunen H, Heinonen OP, Knekt P, Maatela J (1975) The epidemiology of hyperostosis of the spine together with its symptoms and related mortality in a general population. Scand J Rheumatol 4:23–27

    CAS  PubMed  Google Scholar 

  11. Weinfeld RM, Olson PN, Maki DD, Griffiths HJ (1997) The prevalence of diffuse idiopathic skeletal hyperostosis (DISH) in two large American Midwest metropolitan hospital populations. Skeletal Radiol 26:222–225

    Article  CAS  PubMed  Google Scholar 

  12. Bloom RA (1984) The prevalence of ankylosing hyperostosis in a Jerusalem population—with description of a method of grading the extent of the disease. Scand J Rheumatol 13:181–189

    CAS  PubMed  Google Scholar 

  13. Littlejohn GO (1985) Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis. Clin Rheumatol 4:294–300

    CAS  PubMed  Google Scholar 

  14. El Miedany YM, Wassif G, el Baddini M (2000) Diffuse idiopathic skeletal hyperostosis (DISH): Is it of vascular etiology? Clin Exp Rheumatol 18:193–200

    Google Scholar 

  15. Forestier J, Lagier R (1971) Ankylosing hyperostosis of the spine. Clin Orthop 74:65–83

    CAS  PubMed  Google Scholar 

  16. Mata S, Fortin PR, Fitzcharles MA et al. (1997) A controlled study of diffuse idiopathic skeletal hyperostosis. Clinical features and functional status. Medicine 76:104–117

    Article  CAS  PubMed  Google Scholar 

  17. Girolamo M di (1991) Cellular, metabolic and clinical consequences of adipose mass enlargement in obesity. Nutrition 7:287–289

    PubMed  Google Scholar 

  18. Smythe HA (1987) Osteoarthritis, insulin and bone density. J Rheumatol 13 (Suppl): 91–93

    Google Scholar 

  19. Silveri F, Brecciaroli D, Argentati F, Cervini C (1994) Serum levels of insulin in overweight patients with osteoarthritis of the knee. J Rheumatol 21:1899–1902

    CAS  PubMed  Google Scholar 

  20. Charles WD, Betty B, Moskowitz RW (1994) Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis-insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 21:1725–1730

    CAS  PubMed  Google Scholar 

  21. Lakka HM, Lakka TA, Tuomilehto J et al. (2000) Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischemic heart Disease Risk Factor Study. Arch Intern Med 160:1160–1168

    Article  CAS  PubMed  Google Scholar 

  22. Pyorala M, Miettinen H, Laakso M, Pyorala K (2000) Plasma insulin and all-causes, cardiovascular, and noncardiovascular mortality: the 22 year follow-up results of Helsinki Policemen Study. Diabetes Care 23:1097–1102

    PubMed  Google Scholar 

  23. Chu NF, Spiegelman D, Hotamisligil GS et al. (2001) Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis 157:495–503

    Article  CAS  PubMed  Google Scholar 

  24. Lithell HOL (1991) Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care 14:203–209

    CAS  PubMed  Google Scholar 

  25. Julkunen H, Aromaa A, Knekt P (1981) Diffuse idiopathic skeletal hyperostosis (DISH) and spondylosis deformans as predictors of cardiovascular disease and cancer. Scand J Rheumatol 10:241–248

    CAS  PubMed  Google Scholar 

  26. Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022

    CAS  PubMed  Google Scholar 

  27. Vaziri SM, Larson MG, Benjamin EJ, Levy D (1994) Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 89:724–730

    CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. R. Mader

    Present address: The B. Rappaport Faculty of Medicine, The Technion–Israel Institute of Technology, Haifa, Israel

Authors and Affiliations

  1. Rheumatic Diseases Unit, Ha’Emek Medical Center, , 18101, Afula, Israel

    R. Mader

  2. Department of Medicine, Poriah Medical Center, Tiberias, Israel

    N. Dubenski

  3. Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel

    Idit lavi

Authors
  1. R. Mader
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. Dubenski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Idit lavi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Mader.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mader, R., Dubenski, N. & lavi, I. Morbidity and mortality of hospitalized patients with diffuse idiopathic skeletal hyperostosis. Rheumatol Int 26, 132–136 (2005). https://doi.org/10.1007/s00296-004-0529-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-004-0529-y

Keywords

Search

Navigation